I’d happily buy FTSE 100 stock Smith & Nephew despite this chilling news

Royston Wild explains why Smith & Nephew plc (LON: SN) remains a white-hot FTSE 100 (INDEXFTSE: UKX) growth stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

High Speed Background

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve long been a fan of Smith & Nephew’s (LSE: SN) growth credentials and continue to be so, even if latest trading details released on Thursday fell short of the mark.

The builder of artificial joints and limbs was dealing 7% lower at the time of writing, with frightened investor behaviour today no doubt exacerbated by the strong share price run of recent months. 

Established markets in the mire

The FTSE 100 business advised inits upate that revenues rose by a disappointing 5% in the first quarter, to $1.2bn. This upswing was created by foreign exchange tailwinds, however, as underlying sales flatlined in the period.

Should you invest £1,000 in Smith & Nephew Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Smith & Nephew Plc made the list?

See the 6 stocks

This poor performance has led Smith & Nephew to hack back its sales estimates for the full year and it now expects underlying revenue growth to range between 2% and 3% in 2018. The firm added that its trading profit margin will now merely be “at or above that achieved in 2017.”

Just three months ago Smith & Nephew pencilled in a 3% to 4% improvement in underlying sales this year, as well as an uptick in the trading profit margin of between 30 and 70 basis points.

The London-based business noted that trading in its established markets had been particularly worrisome. These territories — responsible for almost 85% of group turnover in 2017, of which the US accounts for around half — saw underlying sales slump 2% in the three months to March.

Smith & Nephew attributed this reversal to “some softer market conditions and weaker performance in Advanced Wound Bioactives.”

Not all bad, though…

It’s not difficult to see why investor appetite has soured so spectacularly today, and additional share price reversals cannot be ruled out in the short-to-medium term as the momentum in its critical segment fades, even if outgoing chief executive Olivier Bohuon tried to put some a positive spin on things.

Bohuon, who will hand over on May 7 to former Alere CEO Namal Nawana, said: “We expect trading conditions to return to more normal levels, which, combined with the continued rollout of new products and our sustained emerging markets performance, gives us confidence in delivering an improving performance trend during the remainder of the year.”

Regardless of whether or not conditions pick up markedly in its established regions, I remain convinced that Smith & Nephew’s bounding progress in lucrative emerging markets provides plenty of reason for stock pickers to keep the faith, as I explained last time out.

The medical mammoth saw revenues in these territories rise an aggregated 15% during January-March, speeding up from the 12% advance punched last year. And underlying sales here rose 9% in the quarter, the company again noting “strong growth from China.

City analysts had been expecting earnings expansion of 1% and 8% in 2018 and 2019 respectively, figures that look sure to fall by the wayside following Wednesday’s statement. But Smith & Nephew’s long term investment case remains robust, and so neither the likelihood of some forecast reductions nor a current forward P/E ratio of 19 times would discourage me from investing today.

Should you invest £1,000 in Smith & Nephew Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Smith & Nephew Plc made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock is down. But it may be far from out!

Tesla stock has crashed this year but its long-term record of value creation is outstanding. So, could this be a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

£3k in savings? That’s plenty to start buying shares and earning passive income!

Christopher Ruane explores how a stock market newcomer could start buying shares with a few thousand pounds and an appetite…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

5 passive income techniques of stock market millionaires

Christopher Ruane details a handful of approaches many successful stock market investors use to grow their passive income streams.

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

Down 42% in a year, here’s why Aston Martin shares could keep falling

Aston Martin shares have destroyed vast amounts of shareholder value since the company listed in 2018. Are they now a…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

FTSE shares: a once in a blue moon chance to get rich?

Christopher Ruane explains why he thinks hunting for blue-chip FTSE bargains in the current market could help an investor build…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

4 stocks Fools have bought for growth and dividends

Sometimes, an investor doesn’t have to make the choice between buying a growth stock or dividend shares! Some investments offer…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Is there no limit to how high Rolls-Royce shares might go?

Christopher Ruane sees some reasons Rolls-Royce shares could continue pushing upwards. But is he persuaded enough about the potential value…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

How much could £20k in a Stocks and Shares ISA be worth in 2030?

UK investors have enjoyed spectacular returns in their Stocks and Shares ISA's over the past five years. Would could the…

Read more »